Joana Goncalves, Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 7,947 shares at $68.38 ($551K) on 2026-06-15, disclosed to the SEC on 2026-06-15.
Scheduled sale ($551k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.38 | 1,636 | $112K | 20.3% |
| 2 | $69.42 | 5,064 | $352K | 63.8% |
| 3 | $69.69 | 947 | $66K | 12.0% |
| 4 | $70.62 | 300 | $21K | 3.8% |
| Total | $69.28 avg | 7,947 | $551K | 100% |
| Filing → |
| ORKA | SELL | 2026-08-17 | $783K | — | Filing → |
| ORKA | SELL | 2026-07-15 | $604K | — | Filing → |
| ORKA | SELL | 2026-05-15 | $433K | — | Filing → |